Journal ArticleOPEN ACCESS

Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study

  • Cooper V
  • Horne R
  • Ewan J
Journal of the International AIDS Society (2010) 13(S4)
DOI: 10.1186/1758-2652-13-s4-p42
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK

Cite

CITATION STYLE

APA

Cooper, V., Horne, R., & Ewan, J. (2010). Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study. Journal of the International AIDS Society, 13(S4). https://doi.org/10.1186/1758-2652-13-s4-p42

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free